{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T10:09:03Z","timestamp":1780567743495,"version":"3.54.1"},"reference-count":62,"publisher":"Oxford University Press (OUP)","issue":"3","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19-AG033655"],"award-info":[{"award-number":["U19-AG033655"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30- AG066507"],"award-info":[{"award-number":["P30- AG066507"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P41EB031771"],"award-info":[{"award-number":["P41EB031771"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S10 OD034232"],"award-info":[{"award-number":["S10 OD034232"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Alzheimer\u2019s disease is defined by the abnormal accumulation of amyloid-\u03b2 (A\u03b2) plaques and tau neurofibrillary tangles, the two hallmark proteinopathies detectable via molecular imaging. A\u03b2 deposition typically begins in neocortical regions and is hypothesized to constitute a permissive condition for the subsequent spread of tau. Tau pathology is known to spread systematically through select brain regions, typically described as Braak stages (I\u2013VI), reflecting the spatiotemporal trajectory of tau distribution with disease progression. Evaluating the associations between regional A\u03b2 accumulation and the spatial distribution of tau remains an important question in understanding disease progression. This study examined the associations between regional A\u03b2 and tau burden, measured by positron emission tomography (PET), in 192 participants without dementia (178 cognitively unimpaired, 14 with mild cognitive impairment [MCI],) in the Biomarkers of Cognitive Decline Among Normal Individuals (BIOCARD) cohort (age range: 32\u201388 years; mean age: 68 years; 58% female), of whom 52 were A\u03b2 positive. A\u03b2 burden was assessed using standardized uptake value ratios (SUVR) obtained from several cortical areas [the medial orbitofrontal cortex (OFC), lateral OFC, precuneus, posterior cingulate, anterior cingulate, parietal, temporal, and superior frontal regions], using 11C-PIB PET. Tau burden was quantified using 18F-MK6240 PET, within regions of interest defined as Braak stages I\u2013VI. Elastic net regression was employed to delineate the association of regional A\u03b2 burden and tau PET accumulation across Braak stages, covarying for age, sex, education, and apolipoprotein E (APOE) \u025b4 carrier status. A\u03b2 burden in the medial OFC showed the strongest association with tau burden in Braak stages I\u2013II. For Braak stage III, tau deposition was most strongly associated with A\u03b2 burden in both the medial OFC and precuneus, while in later Braak stages (IV\u2013V), the precuneus showed the strongest association with tau deposition. These region-specific associations remained robust in sensitivity analyses excluding participants with MCI, underscoring the consistency of these findings. Together, these results show regional differences in A\u03b2-tau associations, with medial OFC A\u03b2 burden being strongly associated with early tau pathology accumulation, while precuneus A\u03b2 burden is associated with tau in later stages. These findings suggest that localized amyloid burden measures may enhance early detection of clinically significant amyloid changes and show utility in understanding A\u03b2-tau dynamics.<\/jats:p>","DOI":"10.1093\/braincomms\/fcag184","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:47:19Z","timestamp":1779277639000},"source":"Crossref","is-referenced-by-count":0,"title":["Tau burden across Braak stages is associated with regionally specific amyloid accumulation"],"prefix":"10.1093","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4667-2534","authenticated-orcid":false,"given":"Nisha","family":"Rani","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine , Baltimore, MD 21287 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylie H","family":"Alm","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine , Baltimore, MD 21287 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel D","family":"Callow","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine , Baltimore, MD 21287 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Johns Hopkins University School of Medicine , Baltimore, MD 21287 ,","place":["USA"]},{"name":"Department of Biostatistics, Johns Hopkins University, Bloomberg School of Public Health , Baltimore, MD 21287 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4264-275X","authenticated-orcid":false,"given":"Corinne","family":"Pettigrew","sequence":"additional","affiliation":[{"name":"Department of Neurology, Johns Hopkins University School of Medicine , Baltimore, MD 21287 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6193-0418","authenticated-orcid":false,"given":"Anja","family":"Soldan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Johns Hopkins University School of Medicine , Baltimore, MD 21287 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin A","family":"Lodge","sequence":"additional","affiliation":[{"name":"Department of Radiology, Johns Hopkins University School of Medicine , Baltimore, MD 21287 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, Johns Hopkins University , Baltimore, MD 21218 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn","family":"Albert","sequence":"additional","affiliation":[{"name":"Department of Neurology, Johns Hopkins University School of Medicine , Baltimore, MD 21287 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold","family":"Bakker","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine , Baltimore, MD 21287 ,","place":["USA"]},{"name":"Department of Neurology, Johns Hopkins University School of Medicine , Baltimore, MD 21287 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"issue":"4","key":"2026060405483571500_fcag184-B1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrneurol.2018.9","article-title":"Imaging tau and amyloid-\u03b2 proteinopathies in Alzheimer disease and other conditions","volume":"14","author":"Villemagne","year":"2018","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"2026060405483571500_fcag184-B2","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s association workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"2026060405483571500_fcag184-B3","first-page":"245","article-title":"Cross-sectional and longitudinal atrophy is preferentially associated with tau rather than amyloid \u03b2 positron emission tomography pathology","volume":"10","author":"Gordon","year":"2018","journal-title":"Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"issue":"14","key":"2026060405483571500_fcag184-B4","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1212\/WNL.0b013e31828ab35d","article-title":"Meta-analysis of amyloid-cognition relations in cognitively normal older adults","volume":"80","author":"Hedden","year":"2013","journal-title":"Neurology"},{"issue":"4","key":"2026060405483571500_fcag184-B5","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","article-title":"Amyloid \u03b2 deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: A prospective cohort study","volume":"12","author":"Villemagne","year":"2013","journal-title":"Lancet Neurol"},{"issue":"4","key":"2026060405483571500_fcag184-B6","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","article-title":"Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry","volume":"112","author":"Braak","year":"2006","journal-title":"Acta Neuropathol"},{"issue":"5","key":"2026060405483571500_fcag184-B7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/BF00294607","article-title":"Neurofibrillary changes confined to the entorhinal region and an abundance of cortical amyloid in cases of presenile and senile dementia","volume":"80","author":"Braak","year":"1990","journal-title":"Acta Neuropathol"},{"issue":"1","key":"2026060405483571500_fcag184-B8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00401-018-1855-6","article-title":"Tau seeding activity begins in the transentorhinal\/entorhinal regions and anticipates phospho-tau pathology in Alzheimer\u2019s disease and PART","volume":"136","author":"Kaufman","year":"2018","journal-title":"Acta Neuropathol"},{"issue":"8","key":"2026060405483571500_fcag184-B9","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.2967\/jnumed.122.265200","article-title":"The use of Tau PET to stage Alzheimer disease according to the Braak staging framework","volume":"64","author":"Macedo","year":"2023","journal-title":"J Nucl Med"},{"issue":"11","key":"2026060405483571500_fcag184-B10","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1093\/brain\/awab248","article-title":"Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages","volume":"144","author":"Pascoal","year":"2021","journal-title":"Brain"},{"issue":"12","key":"2026060405483571500_fcag184-B11","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1093\/brain\/awx243","article-title":"Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer\u2019s disease","volume":"140","author":"Bejanin","year":"2017","journal-title":"Brain"},{"issue":"5","key":"2026060405483571500_fcag184-B12","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","article-title":"Correlation of Alzheimer disease neuropathologic changes with cognitive Status: A review of the literature","volume":"71","author":"Nelson","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"2026060405483571500_fcag184-B13","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.neuron.2014.05.004","article-title":"The intersection of amyloid Beta and Tau at synapses in Alzheimer\u2019s disease","volume":"82","author":"Spires-Jones","year":"2014","journal-title":"Neuron"},{"issue":"7","key":"2026060405483571500_fcag184-B14","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1007\/s00259-021-05191-9","article-title":"Relationship between amyloid and tau levels and its impact on tau spreading","volume":"48","author":"Dor\u00e9","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"2026060405483571500_fcag184-B15","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ana.24546","article-title":"Tau positron emission tomographic imaging in ageing and early Alzheimer disease","volume":"79","author":"Johnson","year":"2016","journal-title":"Ann Neurol"},{"issue":"19","key":"2026060405483571500_fcag184-B16","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1523\/JNEUROSCI.0485-18.2018","article-title":"Subthreshold amyloid predicts Tau deposition in aging","volume":"38","author":"Leal","year":"2018","journal-title":"J Neurosci"},{"issue":"6","key":"2026060405483571500_fcag184-B17","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s43587-022-00204-0","article-title":"Biomarker modeling of Alzheimer\u2019s disease using PET-based Braak staging","volume":"2","author":"Therriault","year":"2022","journal-title":"Nat Aging"},{"key":"2026060405483571500_fcag184-B18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.dadm.2016.12.010","article-title":"Tau-PET uptake: Regional variation in average SUVR and impact of amyloid deposition","volume":"6","author":"Vemuri","year":"2017","journal-title":"Alzheimers Dement (Amst)"},{"issue":"1","key":"2026060405483571500_fcag184-B19","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/brain\/awz378","article-title":"Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age","volume":"143","author":"Betthauser","year":"2020","journal-title":"Brain"},{"issue":"1","key":"2026060405483571500_fcag184-B20","article-title":"Trajectory of clinical symptoms in relation to amyloid chronicity","volume":"14","author":"Birdsill","year":"2022","journal-title":"Alzheimers Dement (Amst)"},{"issue":"6","key":"2026060405483571500_fcag184-B21","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1093\/brain\/awae116","article-title":"Characterizing brain tau and cognitive decline along the amyloid timeline in Alzheimer\u2019s disease","volume":"147","author":"Cody","year":"2024","journal-title":"Brain"},{"issue":"1","key":"2026060405483571500_fcag184-B22","article-title":"Amyloid duration is associated with preclinical cognitive decline and tau PET","volume":"12","author":"Koscik","year":"2020","journal-title":"Alzheimers Dement (Amst)"},{"issue":"1","key":"2026060405483571500_fcag184-B23","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2850","article-title":"Amyloid-\u03b2 PET in Alzheimer\u2019s disease: A systematic review and Bayesian meta-analysis","volume":"13","author":"Ruan","year":"2023","journal-title":"Brain Behav"},{"issue":"5","key":"2026060405483571500_fcag184-B24","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","article-title":"PET imaging of Tau deposition in the aging human brain","volume":"89","author":"Sch\u00f6ll","year":"2016","journal-title":"Neuron"},{"issue":"8","key":"2026060405483571500_fcag184-B25","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2174\/156720501108140910121920","article-title":"Cognitive changes preceding clinical symptom onset of mild cognitive impairment and relationship to ApoE genotype","volume":"11","author":"Albert","year":"2014","journal-title":"Curr Alzheimer Res"},{"issue":"3","key":"2026060405483571500_fcag184-B26","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: Recommendations from the national institute on aging-Alzheimer\u2019s association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"3","key":"2026060405483571500_fcag184-B27","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the national institute on aging-Alzheimer\u2019s association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"2026060405483571500_fcag184-B28","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1272946","article-title":"Tau PET burden in Brodmann areas 35 and 36 is associated with individual differences in cognition in non-demented older adults","volume":"15","author":"Rani","year":"2023","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"2026060405483571500_fcag184-B29","article-title":"Hippocampal microstructure as a measure of cognitive resilience to tau PET burden in older adults","volume":"13","author":"Callow","year":"2026","journal-title":"The Journal of Prevention of Alzheimer\u2019s Disease"},{"issue":"6","key":"2026060405483571500_fcag184-B30","doi-asserted-by":"crossref","DOI":"10.1002\/hipo.70038","article-title":"Tau PET burden is associated with hippocampal microstructure and episodic memory in amyloid positive older adults","volume":"35","author":"Callow","year":"2025","journal-title":"Hippocampus"},{"issue":"4","key":"2026060405483571500_fcag184-B31","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"issue":"1","key":"2026060405483571500_fcag184-B32","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/hbm.22627","article-title":"Automated volumetry and regional thickness analysis of hippocampal subfields and medial temporal cortical structures in mild cognitive impairment","volume":"36","author":"Yushkevich","year":"2014","journal-title":"Hum Brain Mapp"},{"key":"2026060405483571500_fcag184-B33","author":"Yushkevich"},{"issue":"3","key":"2026060405483571500_fcag184-B34","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.neuroimage.2006.01.021","article-title":"An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest","volume":"31","author":"Desikan","year":"2006","journal-title":"NeuroImage"},{"issue":"Pt 3","key":"2026060405483571500_fcag184-B35","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/brain\/awm336","article-title":"11C PiB and structural MRI provide complementary information in imaging of Alzheimer\u2019s disease and amnestic mild cognitive impairment","volume":"131","author":"Jack","year":"2008","journal-title":"Brain"},{"issue":"12","key":"2026060405483571500_fcag184-B36","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1093\/brain\/awv283","article-title":"Different definitions of neurodegeneration produce similar amyloid\/neurodegeneration biomarker group findings","volume":"138","author":"Jack","year":"2015","journal-title":"Brain"},{"issue":"1","key":"2026060405483571500_fcag184-B37","article-title":"Longitudinal CSF Alzheimer\u2019s disease biomarker changes from middle age to late adulthood","volume":"14","author":"Pettigrew","year":"2022","journal-title":"Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"key":"2026060405483571500_fcag184-B38","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-84858-7","volume-title":"The elements of statistical learning","author":"Hastie","year":"; 2009"},{"issue":"2","key":"2026060405483571500_fcag184-B39","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1467-9868.2005.00503.x","article-title":"Regularization and Variable selection via the elastic net","volume":"67","author":"Zou","year":"2005","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"2026060405483571500_fcag184-B40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v033.i01","article-title":"Regularization paths for generalized linear models via coordinate descent","volume":"33","author":"Friedman","year":"2010","journal-title":"J Stat Softw"},{"key":"2026060405483571500_fcag184-B41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v106.i01","article-title":"Elastic net regularization paths for all generalized linear models","volume":"106","author":"Tay","year":"2023","journal-title":"J Stat Softw"},{"issue":"8","key":"2026060405483571500_fcag184-B42","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/jamaneurol.2019.1424","article-title":"Association of amyloid and Tau with cognition in preclinical Alzheimer disease: A longitudinal study","volume":"76","author":"Hanseeuw","year":"2019","journal-title":"JAMA Neurol"},{"issue":"6","key":"2026060405483571500_fcag184-B43","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol Med"},{"issue":"19","key":"2026060405483571500_fcag184-B44","doi-asserted-by":"crossref","first-page":"e1809","DOI":"10.1212\/WNL.0000000000006469","article-title":"Regional amyloid accumulation and cognitive decline in initially amyloid-negative adults","volume":"91","author":"Farrell","year":"2018","journal-title":"Neurology"},{"issue":"6","key":"2026060405483571500_fcag184-B45","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/jamaneurol.2020.0387","article-title":"Association of factors with elevated amyloid burden in clinically normal older individuals","volume":"77","author":"Sperling","year":"2020","journal-title":"JAMA Neurol"},{"issue":"10","key":"2026060405483571500_fcag184-B46","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jamaneurol.2022.2442","article-title":"Spatial extent of amyloid-\u03b2 levels and associations with Tau-PET and cognition","volume":"79","author":"Ozlen","year":"2022","journal-title":"JAMA Neurol"},{"issue":"2","key":"2026060405483571500_fcag184-B47","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.25395","article-title":"The impact of amyloid-beta and tau on prospective cognitive decline in older individuals","volume":"85","author":"Sperling","year":"2019","journal-title":"Ann Neurol"},{"issue":"8","key":"2026060405483571500_fcag184-B48","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.1002\/alz.14036","article-title":"Spatial extent as a sensitive amyloid-PET metric in preclinical Alzheimer\u2019s disease","volume":"20","author":"Farrell","year":"2024","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"3","key":"2026060405483571500_fcag184-B49","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(18)30028-0","article-title":"Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer\u2019s disease: A longitudinal study","volume":"17","author":"Gordon","year":"2018","journal-title":"Lancet Neurol"},{"issue":"7","key":"2026060405483571500_fcag184-B50","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.0488-23.2023","article-title":"Spatiotemporal correlation between amyloid and Tau accumulations underlies cognitive changes in aging","volume":"44","author":"Kim","year":"2024","journal-title":"J Neurosci"},{"issue":"4","key":"2026060405483571500_fcag184-B51","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0197-4580(91)90006-6","article-title":"The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer\u2019s disease","volume":"12","author":"Price","year":"1991","journal-title":"Neurobiol Aging"},{"issue":"5","key":"2026060405483571500_fcag184-B52","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/jamaneurol.2018.4693","article-title":"Sex differences in the association of global amyloid and regional Tau deposition measured by positron emission tomography in clinically normal older adults","volume":"76","author":"Buckley","year":"2019","journal-title":"JAMA Neurol"},{"issue":"1","key":"2026060405483571500_fcag184-B53","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/alz.13432","article-title":"Sex differences in the association between tau PET and cognitive performance in a non-Hispanic White cohort with preclinical AD","volume":"20","author":"Wang","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"1","key":"2026060405483571500_fcag184-B54","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-14159-1","article-title":"Functional brain architecture is associated with the rate of tau accumulation in Alzheimer\u2019s disease","volume":"11","author":"Franzmeier","year":"2020","journal-title":"Nat Commun"},{"issue":"4","key":"2026060405483571500_fcag184-B55","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/cne.23442","article-title":"Topographic organization of orbitofrontal projections to the parahippocampal region in rats","volume":"522","author":"Kondo","year":"2014","journal-title":"J Comp Neurol"},{"key":"2026060405483571500_fcag184-B56","doi-asserted-by":"crossref","DOI":"10.3389\/fnsys.2017.00046","article-title":"Architecture of the entorhinal Cortex A review of entorhinal anatomy in rodents with some comparative notes","volume":"11","author":"Witter","year":"2017","journal-title":"Front Syst Neurosci"},{"issue":"1","key":"2026060405483571500_fcag184-B57","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1038\/s41598-023-29251-2","article-title":"Characteristic cortico-cortical connection profile of human precuneus revealed by probabilistic tractography","volume":"13","author":"Jitsuishi","year":"2023","journal-title":"Sci Rep"},{"issue":"4","key":"2026060405483571500_fcag184-B58","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.3233\/JAD-231362","article-title":"Remote associations between Tau and cortical amyloid-\u03b2 are stage-dependent","volume":"98","author":"Hojjati","year":"2024","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"2026060405483571500_fcag184-B59","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12974-023-02853-3","article-title":"Tau and neuroinflammation in Alzheimer\u2019s disease: Interplay mechanisms and clinical translation","volume":"20","author":"Chen","year":"2023","journal-title":"J Neuroinflammation"},{"issue":"10","key":"2026060405483571500_fcag184-B60","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/s41593-018-0238-6","article-title":"Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases","volume":"21","author":"Jucker","year":"2018","journal-title":"Nat Neurosci"},{"issue":"4","key":"2026060405483571500_fcag184-B61","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae198","article-title":"Alzheimer\u2019s disease neuroimaging initiative (ADNI). disruption in functional networks mediated tau spreading in Alzheimer\u2019s disease","volume":"6","author":"Nabizadeh","year":"2024","journal-title":"Brain Commun"},{"key":"2026060405483571500_fcag184-B62","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.nbd.2014.08.032","article-title":"Intracerebral injection of preformed synthetic tau fibrils initiates widespread tauopathy and neuronal loss in the brains of tau transgenic mice","volume":"73","author":"Peeraer","year":"2015","journal-title":"Neurobiol Dis"}],"container-title":["Brain Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/braincomms\/advance-article-pdf\/doi\/10.1093\/braincomms\/fcag184\/68364865\/fcag184.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/braincomms\/article-pdf\/8\/3\/fcag184\/68364865\/fcag184.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/braincomms\/article-pdf\/8\/3\/fcag184\/68364865\/fcag184.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T09:48:50Z","timestamp":1780566530000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/braincomms\/article\/doi\/10.1093\/braincomms\/fcag184\/8690354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5,5]]}},"URL":"https:\/\/doi.org\/10.1093\/braincomms\/fcag184","relation":{},"ISSN":["2632-1297"],"issn-type":[{"value":"2632-1297","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2026]]},"article-number":"fcag184"}}